Literature DB >> 15896564

Practice effects and the use of alternate forms in serial neuropsychological testing.

Leigh J Beglinger1, Brenda Gaydos, Oranee Tangphao-Daniels, Kevin Duff, David A Kareken, Jane Crawford, Philip S Fastenau, Eric R Siemers.   

Abstract

Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896564     DOI: 10.1016/j.acn.2004.12.003

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  102 in total

1.  A single-case experimental analysis of the effects of ambient prism lenses for an adolescent with developmental disabilities.

Authors:  James T Chok; Derek D Reed; Amanda Kennedy; Frank L Bird
Journal:  Behav Anal Pract       Date:  2010

Review 2.  Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.

Authors:  Kevin Duff
Journal:  Arch Clin Neuropsychol       Date:  2012-02-29       Impact factor: 2.813

3.  Walking while talking: investigation of alternate forms.

Authors:  Tamar C Brandler; Mooyeon Oh-Park; Cuiling Wang; Roee Holtzer; Joe Verghese
Journal:  Gait Posture       Date:  2011-09-23       Impact factor: 2.840

4.  Assessment effects in educational and psychosocial intervention trials: an important but often-overlooked problem.

Authors:  Mi-Kyung Song; Sandra E Ward
Journal:  Res Nurs Health       Date:  2015-03-01       Impact factor: 2.228

5.  Robust cognitive change.

Authors:  Timothy A Salthouse
Journal:  J Int Neuropsychol Soc       Date:  2012-05-18       Impact factor: 2.892

6.  Brief Report: Low-Dose Hydrocortisone Has Acute Enhancing Effects on Verbal Learning in HIV-Infected Men.

Authors:  Leah H Rubin; K Luan Phan; Sheila M Keating; Kathleen M Weber; Pauline M Maki
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

7.  Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.

Authors:  Benedikt Sundermann; Bettina Pfleiderer; Harald E Möller; Wolfram Schwindt; Josef Weglage; Jöran Lepsien; Reinhold Feldmann
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

8.  Use of an automated mobile application to assess effects of nicotine withdrawal on verbal fluency: A pilot study.

Authors:  Serguei V S Pakhomov; Wrenda Teeple; Anne M Mills; Michael Kotlyar
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

9.  Implications of short-term retest effects for the interpretation of longitudinal change.

Authors:  Timothy A Salthouse; Elliot M Tucker-Drob
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

Review 10.  Retest effects in working memory capacity tests: A meta-analysis.

Authors:  Jana Scharfen; Katrin Jansen; Heinz Holling
Journal:  Psychon Bull Rev       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.